These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 18276863

  • 1. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R.
    Science; 2008 Feb 15; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract] [Full Text] [Related]

  • 2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.
    Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G, Tugela Ferry Care and Research (TF CARES) Collaboration.
    J Infect Dis; 2007 Dec 01; 196 Suppl 3():S482-90. PubMed ID: 18181698
    [Abstract] [Full Text] [Related]

  • 3. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R, Schecter GF, Flood J, Porco TC.
    Expert Rev Anti Infect Ther; 2008 Oct 01; 6(5):713-24. PubMed ID: 18847407
    [Abstract] [Full Text] [Related]

  • 4. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
    Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E.
    Int J Tuberc Lung Dis; 2008 Jan 01; 12(1):99-104. PubMed ID: 18173885
    [Abstract] [Full Text] [Related]

  • 5. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, Luh KT, Hsueh PR.
    Clin Infect Dis; 2008 Oct 01; 47(7):e57-63. PubMed ID: 18715157
    [Abstract] [Full Text] [Related]

  • 6. Extensively drug-resistant tuberculosis: epidemiology and management challenges.
    Dheda K, Warren RM, Zumla A, Grobusch MP.
    Infect Dis Clin North Am; 2010 Sep 01; 24(3):705-25. PubMed ID: 20674800
    [Abstract] [Full Text] [Related]

  • 7. Infectious disease. Extensively drug-resistant TB gets foothold in South Africa.
    Cohen J.
    Science; 2006 Sep 15; 313(5793):1554. PubMed ID: 16973846
    [No Abstract] [Full Text] [Related]

  • 8. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR, Gandhi NR, Moodley P, Shah NS, Bohlken L, Moll AP, Pillay M, Friedland G, Sturm AW, Tugela Ferry Care and Research Collaboration.
    J Infect Dis; 2008 Dec 01; 198(11):1582-9. PubMed ID: 18847372
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 01; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 10. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

  • 11. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM.
    Infect Genet Evol; 2012 Jun 15; 12(4):686-94. PubMed ID: 21839855
    [Abstract] [Full Text] [Related]

  • 12. Survival in XDR TB: shifting the curve and shifting the paradigm.
    Martinson NA, Chaisson RE.
    J Acquir Immune Defic Syndr; 2011 Jun 01; 57(2):89-91. PubMed ID: 21522018
    [No Abstract] [Full Text] [Related]

  • 13. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y, Yew WW.
    Int J Tuberc Lung Dis; 2009 Nov 01; 13(11):1320-30. PubMed ID: 19861002
    [Abstract] [Full Text] [Related]

  • 14. Trench warfare in a battle with TB.
    Marshall E.
    Science; 2008 Jul 18; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract] [Full Text] [Related]

  • 15. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A, Mondal R.
    FEMS Immunol Med Microbiol; 2008 Jul 18; 53(2):145-50. PubMed ID: 18479439
    [Abstract] [Full Text] [Related]

  • 16. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J.
    Bull World Health Organ; 2006 Dec 18; 84(12):924-5. PubMed ID: 17242824
    [No Abstract] [Full Text] [Related]

  • 17. [Extensively drug-resistant tuberculosis].
    Lange C, Grobusch MP, Wagner D.
    Dtsch Med Wochenschr; 2008 Feb 18; 133(8):374-6. PubMed ID: 18270922
    [Abstract] [Full Text] [Related]

  • 18. Concomitant increases in spectrum and level of drug resistance in Mycobacterium tuberculosis isolates.
    Sun Z, Zhang J, Song H, Zhang X, Li Y, Tian M, Liu Y, Zhao Y, Li C.
    Int J Tuberc Lung Dis; 2010 Nov 18; 14(11):1436-41, i. PubMed ID: 20937184
    [Abstract] [Full Text] [Related]

  • 19. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.
    Paramasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, Narayanan PR.
    Int J Tuberc Lung Dis; 2010 Feb 18; 14(2):243-6. PubMed ID: 20074419
    [Abstract] [Full Text] [Related]

  • 20. Reversal of misfortunes.
    Cohen J.
    Science; 2013 Feb 22; 339(6122):898-903. PubMed ID: 23430629
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.